Myasthenia gravis in association with allogeneic bone marrow transplantation: Clinical observations, therapeutic implications and review of literature

Bone Marrow Transplantation

Volumn 19, Issue 9, 1997, Pages 939-942

  Mackey, J R ^a   Desai, S ^a   Larratt, L ^b   Cwik, V ^c   Nabholtz, J M ^a  

^a CROSS CANCER INSTITUTE   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

Allogeneic bone marrow transplant; Chronic graft versus host disease; Myasthenia gravis; Review; Thymectomy

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; CHOLINESTERASE INHIBITOR; EDROPHONIUM; GLUCOCORTICOID; HLA ANTIGEN; PREDNISONE; PYRIDOSTIGMINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; DYSPHAGIA; DYSPHONIA; FEMALE; HUMAN; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; PRIORITY JOURNAL; PTOSIS; RESPIRATORY DISTRESS; THYMECTOMY;

EID: 0030917022     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700759     Document Type: Article

References (15)

1. Drachman DB. Medical progress: myasthenia gravis. New Engl J Med 1994; 330: 1797-1810.
2. Bolger GB, Sullivan KM, Spence AM et al. Myasthenia gravis after allogeneic bone marrow transplantation: relationship to chronic graft-versus-host disease. Neurology 1986; 36: 1087-1091.
3. Grau JM, Casademont J, Monforte R et al. Myasthenia gravis after allogeneic bone marrow transplantation: report of a new case and pathogenetic considerations. Bone Marrow Transplant 1990; 5: 435-437.
4. Smith CIE, Aarli JJA, Biberfeld P et al. Myasthenia gravis after bone-marrow transplantation: evidence of a donor origin. New Engl J Med 1983; 309: 1565-1568.
5. Shimoda K, Gondo H, Harada M et al. Myasthenia gravis after allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 14: 155-156.
6. Seely E, Drachman D, Smit BR et al. Post bone marrow transplantation myasthenia gravis: evidence for acetylcholine receptor abnormality. Blood 1984; 64 (Suppl. 1): 221 (Abstr. 793).
7. Atkinson K, Bryant D, Delprado W, Biggs J. Widespread pulmonary fibrosis as a major clinical manifestation of chronic graft-versus-host disease. Bone Marrow Transplant 1989; 4: 129-132.
8. Melms A, Faul C, Sommer N et al. Myasthenia gravis after BMT: identification of patients at risk? Bone Marrow Transplant 1992; 9: 78-79.
9. Zaja, F, Russo D, Silvestri F et al. Myasthenia gravis after allogeneic bone marrow transplantation: a case report. Bone Marrow Transplant 1995; 15: 649-650.
10. Terasaki P. Histocompatibility Testing. UCLA Tissue Typing Laboratory: Los Angeles, 1980, p 962.
11. HLA Desktop Companion. One Lambda, Inc. Publishing: Canoga Park, CA, 1992, p 9.
12. Steinman I. Immunogenetic mechanisms in myasthenia gravis. In: Aquilonius SM, Gillbert PG (eds). Cholinergic Neurotransmission: Functional and Clinical Aspects. Vol 84 of Progress in Brain Research. Elsevier: Amsterdam, 1990, pp 117-124.
13. Carlsson B, Wallin J, Prskanen R et al. Different HLA DR-DQ associations in subgroups of idiopathic myasthenia gravis. Immunogenetics 1990; 31: 285-90.
14. Smith CIE, Norberg R, Moller G et al. Autoantibody formation after bone marrow transplantation. Eur Neurol 1989; 29: 128-134.
15. Buckingham JM, Howard FM Jr, Bernatz PE et al. The value of thymectomy in myasthenia gravis: a computer-assisted matched study. Ann Surg 1976; 184: 453-458.